News from us and our partners

Tags

Topics

0 results

News
5 April, 2022
SafeHeal announces successful launch of pivotal study for Colovac endoluminal bypass sheath
News
5 April, 2022
Catamaran Bio appoints Frank Lee as Chair of its Board of Directors
News
4 April, 2022
Antoine Papiernik speaks at Growing Together Athens event
News
31 March, 2022
AAVantgarde Bio appoints Ram Palanki as Chairman of its Board of Directors
News
30 March, 2022
Redx nominates GI-targeted ROCK Inhibitor, RXC008, as clinical development candidate
News
24 March, 2022
AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results
News
17 March, 2022
CorWave to set up its manufacturing facility and expand to a new site next to Paris
News
17 March, 2022
CinCor Pharma to be Added to Russell 2000® and Russell 3000® Indexes
News
15 March, 2022
DMC appoints Kelly Smith as VP R&D
News
14 March, 2022
The secrets to 50 years of success in life sciences investment
News
14 March, 2022
Catamaran Bio expands collaboration for CAR-NK cell engineering with the University of Minnesota and secures an exclusive patent license to next generation manufacturing technologies
News
10 March, 2022
RefleXion raises $80 million to broaden cancer treatment options
News
10 March, 2022
Abivax reports promising ABX464 phase 2A one-year maintenance results in rheumatoid arthritis
News
8 March, 2022
Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA
News
1 March, 2022
Noema Pharma appoints Michael Gutch as CFO
News
28 February, 2022
Lucia Faccio comments on the increased interest from investors in the rare diseases space

SafeHeal announces successful launch of pivotal study for Colovac endoluminal bypass sheath

Catamaran Bio appoints Frank Lee as Chair of its Board of Directors

Antoine Papiernik speaks at Growing Together Athens event

AAVantgarde Bio appoints Ram Palanki as Chairman of its Board of Directors

Redx nominates GI-targeted ROCK Inhibitor, RXC008, as clinical development candidate

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

CorWave to set up its manufacturing facility and expand to a new site next to Paris

CinCor Pharma to be Added to Russell 2000® and Russell 3000® Indexes

DMC appoints Kelly Smith as VP R&D

The secrets to 50 years of success in life sciences investment

Catamaran Bio expands collaboration for CAR-NK cell engineering with the University of Minnesota and secures an exclusive patent license to next generation manufacturing technologies

RefleXion raises $80 million to broaden cancer treatment options

Abivax reports promising ABX464 phase 2A one-year maintenance results in rheumatoid arthritis

Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA

Noema Pharma appoints Michael Gutch as CFO

Lucia Faccio comments on the increased interest from investors in the rare diseases space